drugset / Trial / NCT01165541

A Study of Quetiapine and Mirtazapine for the Treatment of Alcohol Dependency

NCT01165541

Phase 2 Completed 20 enrolled Dartmouth-Hitchcock Medical Center
Non-randomizedCrossoverOpen-labelTreatment

Summary

The purpose of the study is to test whether taking two medicines (quetiapine and mirtazapine) is better for helping people to decrease drinking than taking one medicine alone (quetiapine).

Timeline

Start
2010-09
Primary completion
2012-10
Completion
2012-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Mirtazapine Other / unclassified 45 mg
Subject Quetiapine fumarate extended release (Quetiapine XR) Unknown 400 mg

Indications